|
TOMM5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.72623999999955E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.04059999692797E-08 |
| Normal-vs-Stage2 |
5.876000E-02 |
| Normal-vs-Stage3 |
2.570600E-04 |
| Normal-vs-Stage4 |
7.146600E-01 |
| Stage1-vs-Stage2 |
2.241000E-01 |
| Stage1-vs-Stage3 |
5.412000E-01 |
| Stage1-vs-Stage4 |
2.116400E-02 |
| Stage2-vs-Stage3 |
4.476400E-01 |
| Stage2-vs-Stage4 |
2.900800E-01 |
| Stage3-vs-Stage4 |
6.596100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.71434999999276E-05 |
| Normal-vs-AfricanAmerican |
2.063800E-02 |
| Normal-vs-Asian |
2.230500E-02 |
| Caucasian-vs-AfricanAmerican |
5.856200E-01 |
| Caucasian-vs-Asian |
6.989600E-01 |
| AfricanAmerican-vs-Asian |
4.801600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.07509999966749E-07 |
| Normal-vs-Female |
2.648100E-02 |
| Male-vs-Female |
6.475900E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.331900E-02 |
| Normal-vs-Age(41-60Yrs) |
2.03069999999972E-05 |
| Normal-vs-Age(61-80Yrs) |
5.035200E-04 |
| Normal-vs-Age(81-100Yrs) |
7.729700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.594800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.085600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.001400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.430200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.058400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.808600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.019000E-04 |
| Normal-vs-Grade 2 |
2.55419999994899E-06 |
| Normal-vs-Grade 3 |
2.01769999998991E-05 |
| Normal-vs-Grade 4 |
6.755400E-01 |
| Grade 1-vs-Grade 2 |
4.061400E-01 |
| Grade 1-vs-Grade 3 |
2.251000E-01 |
| Grade 1-vs-Grade 4 |
2.678100E-02 |
| Grade 2-vs-Grade 3 |
9.556600E-01 |
| Grade 2-vs-Grade 4 |
8.401900E-02 |
| Grade 3-vs-Grade 4 |
9.272100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.217200E-04 |
| Normal-vs-ccB subtype |
2.48349999998343E-06 |
| ccA subtype-vs-ccB subtype |
7.534100E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.768900E-04 |
| Normal-vs-N1 |
6.376000E-01 |
| N0-vs-N1 |
6.319600E-02 |
|
|
